[et_pb_section fb_built=”1″ admin_label=”Team” _builder_version=”4.16″ _module_preset=”default” custom_margin=”|||” custom_padding=”54px|0px|100px|0px” global_colors_info=”{}”][et_pb_row column_structure=”1_3,2_3″ _builder_version=”4.19.4″ _module_preset=”default” background_color=”#ffffff” background_size=”initial” background_position=”top_left” background_repeat=”repeat” custom_margin=”||30px||false|false” custom_padding=”15px|15px|15px|15px|false|false” animation_style=”slide” animation_direction=”bottom” animation_intensity_slide=”6%” animation_starting_opacity=”100%” border_radii=”on|15px|15px|15px|15px” border_color_all=”gcid-0881eb85-6db4-495d-84c3-350d3a9274f0″ border_width_top=”18px” box_shadow_style=”preset3″ box_shadow_vertical=”39px” box_shadow_blur=”80px” box_shadow_color=”rgba(0,0,0,0.1)” custom_width_px=”1280px” locked=”off” global_colors_info=”{%22gcid-0881eb85-6db4-495d-84c3-350d3a9274f0%22:%91%22border_color_all%22%93}”][et_pb_column type=”1_3″ _builder_version=”4.17.4″ _module_preset=”default” custom_padding=”30px|40px|30px|40px” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_image src=”https:\/\/tonetx.eu\/wp-content\/uploads\/2023\/07\/14.png” title_text=”14″ _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”2_3″ _builder_version=”4.17.4″ _module_preset=”default” custom_padding=”30px|40px|30px|40px” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.19.4″ _module_preset=”default” text_font=”Arial||||||||” text_font_size=”17px” header_font=”Arial||||||||” header_font_size=”24px” header_2_font=”Josefin Sans||||||||” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n
<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.19.4″ _module_preset=”default” background_color=”#ffffff” background_size=”initial” background_position=”top_left” background_repeat=”repeat” custom_margin=”||||false|false” custom_padding=”15px|15px|15px|15px|false|false” animation_style=”slide” animation_direction=”bottom” animation_intensity_slide=”6%” animation_starting_opacity=”100%” border_radii=”on|15px|15px|15px|15px” border_color_all=”gcid-0881eb85-6db4-495d-84c3-350d3a9274f0″ border_width_top=”18px” box_shadow_style=”preset3″ box_shadow_vertical=”39px” box_shadow_blur=”80px” box_shadow_color=”rgba(0,0,0,0.1)” custom_width_px=”1280px” locked=”off” global_colors_info=”{%22gcid-0881eb85-6db4-495d-84c3-350d3a9274f0%22:%91%22border_color_all%22%93}”][et_pb_column type=”4_4″ _builder_version=”4.17.4″ _module_preset=”default” custom_padding=”30px|40px|30px|40px” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.19.4″ _module_preset=”default” text_font=”Arial||||||||” text_font_size=”15px” text_line_height=”2em” border_color_all=”rgba(51,51,51,0.12)” border_width_top=”1px” global_colors_info=”{}”]<\/p>\n
Prof. Pier Giuseppe Pelicci is Director of Research and Chairman of the Department of Experimental Oncology of the European Institute of Oncology (IEO), in Milan. He is also full professor at the University of Milan, President of the European School of Molecular Medicine (SEMM), and Scientific Director of Alleanza Contro il Cancro (ACC), a network of 28 cancer research hospitals promoted and coordinated by the Ministry of Health, engaged in the set-up of multicentric mechanism\u2013based clinical trials With a medical degree, a specialty in Internal Medicine and a PhD in Molecular Biology, he devoted his life to research, in the field having major impact on today\u2019s clinical approach of treating cancer patients, such as the identification\/functional characterization of PML-RAR and mutated-NPM oncogenes and the definition of the molecular basis of the current standard targeted treatment More recently, he has been focusing on the biological and molecular characterization of normal and cancer stem cells, on the mechanisms of DNA damage, on relapse acquired chemoresistance in leukaemia, and obesity as cancer risk factor.<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"
Pier Giuseppe Pelicci, PhD, MD Prof. Pier Giuseppe Pelicci is Director of Research and Chairman of the Department of Experimental Oncology of the European Institute of Oncology (IEO), in Milan. He is also full professor at the University of Milan, President of the European School of Molecular Medicine (SEMM), and Scientific Director of Alleanza Contro […]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-1513","page","type-page","status-publish","hentry"],"yoast_head":"\n